C1orf167-AS1

Across TCGA pan-cancer cohorts, C1orf167-AS1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated C1orf167-AS1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher C1orf167-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated C1orf167-AS1 expression acts as an unfavorable survival marker.

READ, UCEC, and SKCM are the cancer types where C1orf167-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	81	view →
UCEC	OS	Tertile	All	0.551	0.698	.003	66	view →
SKCM	OS	Tertile	III,IV	0.277	0.710	.001	39	view →
KIRC	DFS	Tertile	IV	0.348	0.659	.015	36	view →
LIHC	OS	Tertile	All	0.407	0.713	.008	36	view →
PAAD	OS	Tertile	All	0.178	0.645	.002	36	view →
COAD	DFS	Tertile	II,III,IV	0.467	0.760	.028	18	view →
THYM	DFS	Tertile	All	0.174	0.813	.029	9	view →
KIRP	OS	Tertile	II,III,IV	0.599	0.873	.034	3	view →
ESCA	DFS	Tertile	II,III,IV	0.374	0.534	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

C1orf167-AS1–READ (OS)

Open the READ breakdown →